º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Enterprise

Home-testing healthcare firm MyHealthChecked upbeat on new wellness testing products

The AIM listed firm is confident that demand for its travel related Covid tests will remain strong

MyHealthChecked

Cardiff-based consumer home-testing healthcare company, MyHealthChecked, is poised to expand into wellness products as it continues to be one of the º£½ÇÊÓÆµ’s leading providers of paid for Covid tests.

The Alternative Investment Market listed firm, which is expected to shortly reveal financial results for 2021, has been a major supplier during the pandemic of paid for and mainly travel related PCR and lateral flow tests to retailers as well as direct to consumers.

Chief executive Penny McCormick said: “The evolution of our wider portfolio is around wellness with our first products launching in April. The wellness tests, alongside our enhanced digital platform, provide indications around weight management, vitamin deficiency, food intolerances, heart health and blood glucose. We expect these tests and accompanying digital outputs to be the first in a new portfolio of long-term growth drivers for our business.

"Using swabs, which are simpler than a Covid test, they are sent off to the laboratory and from that you then get information around your predisposition and the outputs on what you need to do about that.

" We are planning quite a unique personalisation offering in the second half of this year, as getting a personalised wellness and really trying to understand what ‘do I need to’ we consider to be a real growth area in the market.”

Unlike the highly competitive marketplace in the º£½ÇÊÓÆµ for Covid testing, which for MyHealthChecked like many suppliers source products from China, margins will be higher in what is a less crowded wellness marketplace.

Penny McCormick

Ms McCormick said there is also potential for its new range of wellness testing products to be sold in overseas markets She added: “You could do it outside of the º£½ÇÊÓÆµ because there is less time sensitivity of sending samples back (to the º£½ÇÊÓÆµ), but local regulations do vary. France for example is far stricter and the US is an established market for these sort of tests. However, the Middle East and Asia we see as potential targets.”